{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:05:57Z","timestamp":1740107157242,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recurrent and disseminated pityriasis versicolor (RDPV) is a common clinical entity, characterized by its recurrent and disfiguring nature. Studies demonstrated host genetic variations in the immune response, especially the role of IL-17 in antifungal immunity. This study aimed to\u00a0detect whether IL-17A and F gene polymorphisms are found in cases of RDPV. It included 100 cases of RDPV and 100 age and sex matched controls, from\u00a0which EDTA blood samples were taken for single-nucleotide polymorphism analysis. IL-17A (rs2275913) and F (rs763780) were associated with a significantly increased incidence of developing RDPV. IL-17A and F gene polymorphism could be implicated as a risk factor for the development of RDPV.<\/jats:p>","DOI":"10.1007\/s00403-022-02462-9","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:03:55Z","timestamp":1669817035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of IL-17A and IL-17F gene polymorphism in recurrent and disseminated pityriasis versicolor: a case-control study"],"prefix":"10.1007","author":[{"given":"S. R.","family":"El-Tahlawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-0929","authenticated-orcid":false,"given":"R. F.","family":"Hilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"issue":"2","key":"2462_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/QCO.0b013e328324ed19","volume":"22","author":"G Gaitanis","year":"2009","unstructured":"Gaitanis G, Bassukas ID, Velegraki A (2009) The range of molecular methods for typing Malassezia. Curr Opin Infect Dis 22(2):119\u2013125","journal-title":"Curr Opin Infect Dis"},{"key":"2462_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mehy.2017.10.013","volume":"109","author":"K Romero-Sandoval","year":"2017","unstructured":"Romero-Sandoval K et al (2017) Recurrent and disseminated pityriasis versicolor: a novel clinical form consequent to Malassezia-host interaction? Med Hypotheses 109:139\u2013144","journal-title":"Med Hypotheses"},{"issue":"1","key":"2462_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1468-3083.2002.00378.x","volume":"16","author":"AK Gupta","year":"2002","unstructured":"Gupta AK, Bluhm R, Summerbell R (2002) Pityriasis versicolor. J Eur Acad Dermatology Venereol 16(1):19\u201333","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"6","key":"2462_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1590\/S0365-05962010000600004","volume":"85","author":"PM de Morais","year":"2010","unstructured":"de Morais PM, da Maria GSC, Frota MZM (2010) \u201cClinical aspects of patients with pityriasis versicolor seen at a referral center for tropical dermatology in Manaus, Amazonas, Brazil. An Bras Dermatol 85(6):797\u2013803","journal-title":"An Bras Dermatol"},{"issue":"9","key":"2462_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361(9):888\u2013898","journal-title":"N Engl J Med"},{"issue":"4","key":"2462_CR6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL (2019) The IL-17 family of cytokines in health and disease. Immunity 50(4):892\u2013906","journal-title":"Immunity"},{"issue":"9","key":"2462_CR7","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/eji.201242605","volume":"42","author":"S Cypowyj","year":"2012","unstructured":"Cypowyj S, Picard C, Mar\u00f3di L, Casanova J, Puel A (2012) Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol 42(9):2246\u20132254","journal-title":"Eur J Immunol"},{"issue":"3","key":"2462_CR8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4049\/jimmunol.162.3.1246","volume":"162","author":"T Aarvak","year":"1999","unstructured":"Aarvak T, Chabaud M, Miossec P, Natvig JB (1999) IL-17 is produced by some proinflammatory Th1\/Th0 cells but not by Th2 cells. J Immunol 162(3):1246\u20131251","journal-title":"J Immunol"},{"issue":"10","key":"2462_CR9","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.4049\/jimmunol.167.10.6015","volume":"167","author":"M Chabaud","year":"2001","unstructured":"Chabaud M, Page G, Miossec P (2001) Enhancing effect of IL-1, IL-17, and TNF-\u03b1 on macrophage inflammatory protein-3\u03b1 production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol 167(10):6015\u20136020","journal-title":"J Immunol"},{"issue":"6","key":"2462_CR10","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez F et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183(6):2593\u20132603","journal-title":"J Exp Med"},{"issue":"9","key":"2462_CR11","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.4049\/jimmunol.1001153","volume":"185","author":"S Kagami","year":"2010","unstructured":"Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A (2010) IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 185(9):5453\u20135462","journal-title":"J Immunol"},{"issue":"6","key":"2462_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cytogfr.2010.10.002","volume":"21","author":"JM Reynolds","year":"2010","unstructured":"Reynolds JM, Angkasekwinai P, Dong C (2010) IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev 21(6):413\u2013423","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"2462_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102429","volume":"19","author":"JMGR de Morales","year":"2020","unstructured":"de Morales JMGR et al (2020) Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies. Autoimmun Rev 19(1):102429","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2462_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","volume":"129","author":"RM Onishi","year":"2010","unstructured":"Onishi RM, Gaffen SL (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129(3):311\u2013321","journal-title":"Immunology"},{"issue":"6","key":"2462_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ni.3742","volume":"18","author":"M Veldhoen","year":"2017","unstructured":"Veldhoen M (2017) Interleukin 17 is a chief orchestrator of immunity. Nat Immunol 18(6):612\u2013621","journal-title":"Nat Immunol"},{"issue":"12","key":"2462_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.71","volume":"5","author":"S Okada","year":"2016","unstructured":"Okada S, Puel A, Casanova J, Kobayashi M (2016) Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Clin Transl Immunol 5(12):e114","journal-title":"Clin Transl Immunol"},{"issue":"6025","key":"2462_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","volume":"332","author":"A Puel","year":"2011","unstructured":"Puel A et al (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science (80-) 332(6025):65\u201368","journal-title":"Science (80-)"},{"issue":"4","key":"2462_CR18","first-page":"149","volume":"45","author":"YH Chan","year":"2004","unstructured":"Chan YH (2004) Biostatistics 202: logistic regression analysis. Singapore Med J 45(4):149\u2013153","journal-title":"Singapore Med J"},{"issue":"24","key":"2462_CR19","first-page":"1","volume":"140","author":"YH Chan","year":"2003","unstructured":"Chan YH (2003) Biostatistics 102: quantitative data\u2013parametric and non-parametric tests. Blood Press 140(24):1\u201379","journal-title":"Blood Press"},{"issue":"10","key":"2462_CR20","first-page":"498","volume":"44","author":"YH Chan","year":"2003","unstructured":"Chan YH (2003) Biostatistics 103: qualitative data-tests of independence. Singapore Med J 44(10):498\u2013503","journal-title":"Singapore Med J"},{"issue":"3","key":"2462_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.chom.2019.02.002","volume":"25","author":"F Sparber","year":"2019","unstructured":"Sparber F et al (2019) The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation. Cell Host Microbe 25(3):389\u2013403","journal-title":"Cell Host Microbe"},{"key":"2462_CR22","first-page":"725","volume":"13","author":"W Li","year":"2020","unstructured":"Li W, Shi W, Yin Y, Chen J, Luo L (2020) Association of IL-17 and IL-23 gene variants with plasma levels and risk of vulvovaginal candidiasis in a Chinese Han population. Pharmgenomics Pers Med 13:725","journal-title":"Pharmgenomics Pers Med"},{"key":"2462_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3389\/fmicb.2014.00483","volume":"5","author":"DC Rosentul","year":"2014","unstructured":"Rosentul DC et al (2014) Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol 5:483","journal-title":"Front Microbiol"},{"issue":"2","key":"2462_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jdermsci.2020.12.003","volume":"101","author":"J Hiruma","year":"2021","unstructured":"Hiruma J et al (2021) Blockade of the IL-17 signaling pathway increased susceptibility of psoriasis patients to superficial fungal infections. J Dermatol Sci 101(2):145\u2013146","journal-title":"J Dermatol Sci"},{"key":"2462_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jdcr.2021.10.008","volume":"18","author":"HS Alam","year":"2021","unstructured":"Alam HS, Ward JM, Davis LS (2021) Generalized tinea versicolor following initiation of ixekizumab therapy. JAAD Case Rep 18:54\u201356","journal-title":"JAAD Case Rep"},{"issue":"1","key":"2462_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12903-021-01653-6","volume":"21","author":"BLS Picciani","year":"2021","unstructured":"Picciani BLS, Dziedzic A, Werneck JT et al (2021) Atypical oral candidiasis in a psoriatic patient during targeted immunotherapy with an interleukin 17 inhibitor (secukinumab). BMC Oral Health 21(1):1\u20136","journal-title":"BMC Oral Health"},{"issue":"3","key":"2462_CR27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/adj.12833","volume":"66","author":"CS Farah","year":"2021","unstructured":"Farah CS (2021) Concurrent chronic hyperplastic candidosis and oral lichenoid lesion as adverse events of secukinumab therapy. Aust Dent J 66(3):340\u2013345","journal-title":"Aust Dent J"},{"issue":"2","key":"2462_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.riam.2016.05.004","volume":"34","author":"JC Galvis-Mar\u00edn","year":"2017","unstructured":"Galvis-Mar\u00edn JC, Rodr\u00edguez-Bocanegra MX, Pulido-Villamar\u00edn ADP, Casta\u00f1eda-Salazar R, Celis-Ram\u00edrez AM, Linares-Linares MY (2017) In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27\u2013A3 microdilution and Etest\u00ae methods. Rev Iberoam Micol 34(2):89\u201393","journal-title":"Rev Iberoam Micol"},{"issue":"1","key":"2462_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/CMR.15.1.21-57.2002","volume":"15","author":"HR Ashbee","year":"2002","unstructured":"Ashbee HR, Evans EGV (2002) Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 15(1):21\u201357","journal-title":"Clin Microbiol Rev"},{"key":"2462_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1590\/S0365-05962011000400015","volume":"86","author":"PR Criado","year":"2011","unstructured":"Criado PR, de Oliveira CB, Dantas KC, Takiguti FA, Benini LV, Vasconcellos C (2011) Superficial mycosis and the immune response elements. An Bras Dermatol 86:726\u2013731","journal-title":"An Bras Dermatol"},{"issue":"2","key":"2462_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00403-013-1406-x","volume":"306","author":"N Karakus","year":"2014","unstructured":"Karakus N, Yigit S, Rustemoglu A, Kalkan G, Bozkurt N (2014) Effects of interleukin (IL)-6 gene polymorphisms on recurrent aphthous stomatitis. Arch Dermatol Res 306(2):173\u2013180","journal-title":"Arch Dermatol Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02462-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02462-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02462-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T22:41:35Z","timestamp":1678833695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02462-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":31,"alternative-id":["2462"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02462-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"\u00a0All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical committee approval by the Research Ethics Committee, Faculty of Medicine, Cairo University. Study registered in Protocol Registration and Results System (clincaltrials.gov). NCT04769804.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}